The curious case of Gαs gain-of-function in neoplasia-Reference-Cited by-同舟云学术

The curious case of Gαs gain-of-function in neoplasia

Published:2018-03-15 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Innamorati Giulio^ORCID,Wilkie Thomas M.,Kantheti Havish S.,Valenti Maria Teresa,Dalle Carbonare Luca,Giacomello Luca,Parenti Marco,Melisi Davide,Bassi Claudio

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-4133-z.pdf

Reference171 articles.

1. O'Hayre M, Vazquez-Prado J, Kufareva I, Stawiski EW, Handel TM, Seshagiri S, Gutkind JS: The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev. 2013;13(6):412–24. https://doi.org/10.1038/nrc3521 .

2. Rasmussen SG, DeVree BT, Zou Y, Kruse AC, Chung KY, Kobilka TS, Thian FS, Chae PS, Pardon E, Calinski D, et al. Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature. 2011;477(7366):549–55.

3. Birnbaumer L. Expansion of signal transduction by G proteins. The second 15 years or so: from 3 to 16 alpha subunits plus betagamma dimers. Biochimica et biophysica acta. 2007;1768(4):772–93.

4. Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, et al. Mutations in GNA11 in uveal melanoma. New Eng J Med. 2010;363(23):2191–9.

5. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR, et al. Two G protein oncogenes in human endocrine tumors. Science. 1990;249(4969):655–9.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pilot study to evaluate tissue- and plasma-based DNA driver mutations in a cohort of patients with pancreatic intraductal papillary mucinous neoplasms;G3 Genes|Genomes|Genetics;2022-12-01

2. Oncogene addiction to GNAS in GNASR201 mutant tumors;Oncogene;2022-07-25

3. cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach;Cells;2022-06-24

4. Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma;Cancers;2022-01-29

5. Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei;Journal for ImmunoTherapy of Cancer;2021-10